Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups

This is an earlier presentation of the osteoporosis NCO methodology (see Rows 15 and 50). Initial conference presentation establishing that NCOs can assess comparability of osteoporosis treatment groups in a real-world study with known confounding by frailty and bone density.

Target RWE researchers presented the NCO methodology applied to osteoporosis treatment groups at ISPOR 2018, demonstrating how NCO balance or imbalance reveals residual confounding and providing early empirical evidence for NCO utility.

Earliest conference dissemination of the osteoporosis NCO application establishes the evidentiary foundation for subsequent NCO publications and positions Target RWE's NCO methodology as scientifically validated.

Initial NCO application dissemination for osteoporosis treatment comparability assessment, Early conference evidence for NCO methodology utility in frailty-confounded comparative effectiveness studies